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Adenovirus early region 1A (AdE1A) binds to the C-terminal binding protein 1 (CtBP1) primarily through a highly conserved PXDLS motif
located close to its C-terminus. Purified synthetic peptides equivalent to this region of AdE1A have been shown to form a series of β-turns. In this
present study the effect of CtBP1 binding on the conformation of C-terminal region of Ad12E1A has been investigated. Using one- and two-
dimensional 1H NMR spectroscopy, the conformation of 20-residue peptides equivalent to amino acids I241–V260 and E247–N266 of Ad12E1A
were examined in the absence of CtBP1. Whilst the latter peptide forms a series of β-turns in its C-terminal half as reported previously, the former
peptide is α-helical over the region D243–Q253. Upon interaction with CtBP1 the conformation of the backbone in the region 255PVDLCVK261 of
the Ad12E1A E247–N266 peptide reorganises from a predominately β-turn to an α-helical conformation. This structural isomerisation is
characterised by a shift upfield of 0.318 ppm for the δ-CH3 proton resonance of V
256. 2-D NOESYexperiments showed new signals in the amide-
α region which correlate to transferred NOEs from the protein to the peptide residues E251, V256 and K261. In further analyses the contribution of
individual amino acids within the sequence 254VPVDLS259 was assessed for their importance in determining structure and consequently affinity of
the peptide for CtBP. It has been concluded that Ad12E1A residues 255P–V260 serve initially as a recognition site for CtBP and then as an anchor
through a β-turns→α-helix conformational rearrangement. In addition it has been predicted that regions N-terminal to the PXDLS motif in
AdE1As from different virus serotypes and from mammalian proteins form α-helices.
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Adenovirus early region 1A (AdE1A) is the first protein
expressed following viral infection and is an essential initiator
of adenovirus mediated transformation of human and rodent
cells in culture (reviewed in Gallimore and Turnell, 2001;
Frisch and Mymryk, 2002; Endter and Dobner, 2003; Berk,
2005). Two major AdE1A proteins are expressed from 13S and
12S mRNAs. These proteins in Ad12 are of 266 and 235
amino acids respectively and are identical except for the
presence of transcriptional activation and oncogenic spacer
domains towards the C-terminus of the larger molecule. Com-⁎ Corresponding author. Fax: +44 121 414 4486.
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doi:10.1016/j.virol.2007.01.039parison of the amino acid sequences of AdE1As from dif-
ferent virus serotypes has revealed four conserved regions
(CR1–4) (Avvakumov et al., 2002, 2004). These amino acid
sequences, together with the N-terminal α-helical region, en-
compass the binding sites for multiple AdE1A binding partners
(Gallimore and Turnell, 2001; Frisch and Mymryk, 2002; Berk,
2005).
It is now well established that AdE1A affects the host cell by
means of various protein–protein interactions—for example
binding to the pRb family of proteins through sites in CR1 and
CR2 or to CBP/p300 through sites in the N-terminal region and
CR1 is sufficient to induce cell cycle progression of infected
cells in G0 into S phase (Eckner et al., 1994; Dyson et al., 1989;
Dyson et al., 1992; Howe et al., 1990; Arany et al., 1995:
Lipinski et al., 1999). Interaction with a variety of transcription
factors and associated proteins through CR3 is required for
expression of other viral early region genes (reviewed in Jones,
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binding partners have been mapped to exon 1-encoded regions.
However, a limited number of proteins associate with exon 2
sequences. The best characterised of these is C-terminal binding
protein (CtBP) which interacts primarily, but perhaps not
exclusively, with a short PXDLS sequence located close to the
C-terminus of all AdE1As. This site is directly adjacent to the
nuclear localisation signal (Boyd et al., 1993; Schaeper et al.,
1995; Lyons et al., 1987).
Two CtBP genes have been mapped in mammals, encoding
CtBP1 and CtBP2, and both of these proteins are expressed as
multiple splice variants (reviewed in Chinnadurai, 2002, 2004,
2006; Bergamon and Blaydes, 2006). CtBP homologues are
very widely expressed having been identified in lower
vertebrates, insects and plants (Brannon et al., 1999; Folkers
et al., 2002; Poortinga et al., 1998; Kim et al., 2002). CtBP
appears to function mainly as a transcriptional co-repressor,
generally interacting with proteins containing PXDLS motifs.
In the well-characterised Drosophila system it binds to short
and long-range repressors, playing an important role in
embryonic development (Poortinga et al., 1998; Nibu et al.,
1998a, 1998b; Zhang and Levine, 1999). In mammals
interactions with a number of repressors have been reported
such as BKLF (Turner and Crossley, 1998), FOG (Fox et al.,
1999) and Net1 (Criqui-Filipe et al., 1999) and it has been
suggested that repression can be effected by recruitment of
histone deacetylases, which also interact with CtBP (Zhang et
al., 2001; Subramanian and Chinnadurai, 2003).
Within the context of adenovirology it appears that
interaction of AdE1A with CtBP is necessary for optimal
infectivity with loss of CtBP binding reducing the rate of
expression of viral early region proteins (Grand et al., 2006).
Interestingly, the effects of deletion of the AdE1A CtBP binding
site on transformation are dependent on the co-operating
oncogene. Transformation by AdE1A with mutant ras is
potentiated by deletion of the CtBP binding site whereas
transformation by E1A with AdE1B is appreciably reduced
(Subramanian et al., 1989, 1991; Douglas et al., 1991; Boyd et
al., 1993; Quinlan and Douglas, 1992). Although the PXDLS
motif is essential for the interaction surrounding amino acids
contribute to the binding reaction. The lysine residue, present
just C-terminal to PXDLS in AdE1A, and many other CtBP
binding proteins, can be acetylated by CBP/p300 and pCAF,
reducing but not totally negating binding (Zhang et al., 2000;
Molloy et al., 2006). Moreover, it has been shown that peptides
containing identical PXDLS motifs but with differing surround-
ing sequences have different affinities for CtBP (Molloy et al.,
1998, 2000, 2001). Significantly, intact AdE1A protein binds to
CtBP with higher affinity than does an exon 2 polypeptide and
this, in turn, binds with higher affinity than does a short peptide
identical to the C-terminal region of AdE1A (Molloy et al.,
2000). Previously, we have shown that synthetic peptides
identical to CtBP binding motifs in viral, mammalian and insect
proteins adopt β-turn structures in solution (Molloy et al., 1998,
2001). We have also shown that this is partially disrupted by
acetylation at the lysine residue C-terminal to PXDLS (Molloy
et al., 2006). In the present study the structural consequences ofCtBP binding for synthetic peptides identical to the C-terminal
region of Ad12E1A have been examined by NMR spectro-
scopy. It has been shown that regions N-terminal to PXDLS
adopt a helical confirmation and this is extended throughout the
PXDLS motif following interaction. The structural effects of
certain substitutions in the Ad12 CtBP binding motif have also
been examined.
Results
We have previously demonstrated that a 20 a.a. peptide
identical to residues 247EEEREQTVPVDLSVKRPRCN266
within Ad12E1A (Peptide 1; Fig. 1) adopts a series of β-turns
in solution (Molloy et al., 1998) and that acetylation of K261
disrupts one of the turns reducing the peptide's binding affinity
for CtBP1 (Molloy et al., 2006). In contrast to those data, a
recent crystallographic study showed that an 8 a.a. peptide of
sequence PIDLSVKK adopts an extended conformation upon
binding to CtBP3/BARS (Nardini et al., 2003). It was therefore
felt to be of considerable interest to examine further the
structures adopted by residues that reside both within and
external to the PXDLS motif and determine the effect of CtBP1
binding on the structure of the wild type peptide (Peptide 1; Fig.
1). It was also considered that this study would help us to
understand, to some extent, the constraints and implications of
interactions with AdE1A for CtBP1.
Structural determinants in E1A, N-terminal to the PXDLS
motif, contributing to the interaction with CtBP1
On a number of occasions (Molloy et al., 1998, 2000, 2001,
2006) we have observed that residues N-terminal to the PXDLS
motif also contribute to the binding interactions of synthetic
peptides with CtBP1. In order to assess the structural
determinants of amino acids N-terminal to the PXDLS motif,
we investigated the structure of peptide 2 (Fig. 1) by NMR
spectroscopy. This peptide encompasses residues 241I–V260 of
Ad12E1A and includes six residues N-terminal to the original
peptide examined (Molloy et al., 1998) and fourteen N-terminal
to the PVDLS motif.
Our initial data using ELISA techniques to determine the
relative binding affinity of peptide 2 for CtBP1 showed that it
interacts with the protein with a relative binding affinity of
3 μM (Fig. 1). Having established that the peptide has a high
affinity for CtBP1, its structural properties were examined by 2-
D 1H NMR spectroscopy to allow full assignment of proton
signals within (TOCSY in Fig. 2(A)) and through-space NOEs
between amino acids within the peptide (NOESY in Fig. 2(B)).
Its calculated structure is presented in Fig. 2(C). NOEs of the
type dαN(i,i+2) I
241–D243, E249–E251, R250–Q252, P255–D257,
dNN(i,i+2) I
241–D243, L242–L244, L244–Q246, E248–R250, dαN
(i,i+3) D243–Q246, L242–I245, I245–E248, E247–R250 and E249–
Q252, where the intensities of dαN(i,i+3) NOEs were higher
than for dαN(i,i+2) over the region I
241–Q252 confirm that
residues 241ILDLIQEEER250 adopt an α-helical conformation
(Fig. 2(C)). Significantly, NOEs of the type dαN(i,i+2) P
255–
D257, V256–L258 reveals that residues P255–S259 adopt a β-turn
Fig. 1. Amino acid sequences of Ad1213SE1A peptides. The sequence of the C-terminus of wt Ad12 (residues 241–266) 13SE1A is shown with the C-terminal
binding protein binding motif, PVDLS shown (bold typeset). The sequences of synthetic peptides equivalent to the C-terminus of E1A (Peptides 1 and 2) or which
carry deletions across (Peptides 3 to 10) or substitutions within (Peptides 11, 12 and 13) the PVDLS motif are presented. The ability of synthetic peptides equivalent to
the C-terminus of Ad12E1A to inhibit the interaction between CtBP and Ad1213SE1A was assessed by ELISA and/or fluorescence spectroscopic titration (see
Materials and methods) and values for Kd were determined from the averaged data from four experiments (±S.E.) for all peptides with best fit of the data by the
standard binding equation (Molloy et al., 1998).
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the structural integrity of the CtBP1-binding site is maintained
in this peptide (Fig. 2(C)).
Interactions between CtBP1 and Ad12E1A peptide 247E–N266
To assess the contribution of individual amino acids over
the sequence 241I–N266 of Ad12E1A to the interactions with
GST-CtBP1, an NMR spectroscopic approach was again
adopted. Initial studies focussed on Peptide 1 which had been
well-characterised previously (Molloy et al., 1998). The
peptide was initially examined in the presence of GST as a
control but no discernible changes in its 1-D spectrum were
seen (data not shown). One-dimensional 1H NMR spectra of
Peptide 1 in 10% (v/v) 2H2O were recorded in the absence
(Fig. 3(A)) and presence of GST-CtBP1 (Fig. 3(B)).
Individual assignments were made based upon the observa-
tions of Molloy et al. (1998) and from 2-D 1H NMR
experimentation (data not shown). In the presence of GST-
CtBP1, a number of differences could be seen in the 1-D
spectra after subtraction of GST-CtBP1 protein background
(Fig. 3(B)). In particular, a signal assigned to the δ-CH3
proton resonance of V256 moved 0.1 ppm upfield in the
aliphatic region (Fig. 3(B)) (signal labelled*, cf wild type;
Fig. 3(A)). It is plausible that V256 experienced local field
fluctuations owing to the close proximity (ca ∼5 Å) of an
aromatic residue from CtBP1 and consequently resonated at a
higher frequency. In addition, we noted the presence of a new
signal at 0.7 ppm (Fig. 3(B) signal labelled ⇓). In the
downfield region of the peptide spectrum, amide-NH signals
of E251, Q252, D257, S259, T253, V254, R262 and N266 became
appreciably overlapped. Similarly, changes were observed in
the amide signal for E248 and in signals for V260 and K261 on
GST-CtBP1 binding (Fig. 3(B)). Even though the spectrum
represents an average conformation due to fast exchangebetween the bound- and free-conformers, these findings
suggest most, if not all, residues within Peptide 1 are
influenced by the presence of GST-CtBP1. It is likely that this
occurs through CtBP1-induced local structural changes within
the peptide upon interaction. However, it cannot be ruled out
that the peptide exists in a number of conformational states, a
limited number of which bind CtBP preferentially.
Conformation of the 20 a.a. Ad12 peptide 247E-N266 in the
presence of CtBP1
The data presented above clearly suggest that the Ad12
peptide binds to CtBP1, consistent with previous observations
(Molloy et al., 1998, 2000, 2001, 2006). In order to assess the
structural implications for Peptide 1 of interaction with CtBP1,
we examined the conformation of this peptide in the absence of
trifluoroethanol (TFE) as this could have structural repercus-
sions for CtBP1 and might cause aggregation of the protein.
Peptide 1 was examined by 2-D 1H NMR and in the results from
TOSCYexperiments the proton signals showed good dispersion
in the amide-α region revealing that the peptide remained in
solution in 10% 2H2O (data not shown). In NOESYexperiments
(data not shown), although NOEs observed were weaker than
corresponding spectra of Peptide 1 in TFE (Molloy et al., 1998,
2006), we noted that it adopts a series of β-turns equivalent to
those previously reported (Molloy et al., 1998, 2006). Having
established that TFE enhances the solution structure only in
terms of the strength of NOEs, the conformation of the peptide
in the presence of CtBP1 could be examined in greater detail
than that provided in one-dimensional spectra. In this case, two-
dimensional experiments, namely TOCSY (data not shown) and
NOESY (Fig. 4(A)), were recorded at a ratio of peptide to protein
of 50:1 where fast exchange conditions apply and the
contribution to peptide signals from the protein would be
negligible.
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NOESYexperiment (200 ms mixing time) are shown along with
the calculated structure for the Ad12 peptide when bound to
CtBP1 (illustrated in Fig. 4). In the absence of medium-range
NOEs, for example dαN(i,i+2) and dαN(i,i+3), the conforma-
tion over residues P263–N266 was ill-defined (Fig. 4(B))comparable to our previous findings (Molloy et al., 1998,
2006). In the absence of GST-CtBP1 it has previously been
shown that residues at the N-terminus (E251–V254) of the
peptide adopt a predominately random coil conformation. In the
presence of CtBP1, however, NOEs of the type dαN(i,i+2)
E251–T253 and dαN(i,i+3) E
251–V254 indicate that amino acids
in this region adopt a distinct conformational preference and
form a type I turn (Fig. 4(B)). These findings are consistent with
previous observations that residues outside the PXDLS motif
contribute significantly to the interaction with CtBP1 (Molloy et
al., 1998) and it is now clear that amino acids N-terminal to
PXDLS make such a contribution.
Over the remainder of the well-ordered portion of Peptide 1
(Fig. 4(B); P255–K261), NOEs of the type dαN(i,i+2) V
256–
L258, D257–S259; dαN(i,i+3) V
254–D257, S259–R264; dNN(i,i+
2) L258–V260 and dNN(i,i+3) V
254–D257 were observed in the
presence of CtBP1 (Fig. 4(A)). It was found that the relative
magnitude of dαN(i,i+2) NOEs was, however, equal to the dαN
(i,i+3) cross-peaks and therefore define a helical conformation
over residues P255–R262, in contrast to previously reported data
where the dαN(i,i+2) were stronger than the dαN(i,i+3) NOEs
defining β-turns (Molloy et al., 1998, 2006). It would,
therefore, appear that GST-CtBP1 induces a structural isomer-
isation in the backbone conformation of residues that form the
binding site for CtBP1 on E1A (Fig. 4(B)).
From the data described above it appears that the
conformational change within the peptide backbone associa-
ted with CtBP1 binding also accounts for new signals within
the NOESY experiment (Fig. 4(A)). Presumably these re-
present transferred NOEs between protons within CtBP1 thatFig. 2. 1H NMR assignments for the 20-a.a. Ad12 Peptide 2 (241I–V260). (A) The
downfield amide region of a one-dimensional spectrum (upper panel) and the
amide-α region of a two-dimensional TOCSY experiment (mixing time, 60 ms
duration) collected on a sample of Peptide 2 (at a concentration of 6 mg/ml) of
sequence 241ILDLIQEEEREQTVPVDLSV260 in 50% (v/v) TFE/40%H2O/10%
2H2O, pH 5.5, at 285 K is shown. Residue assignments were identified from
individual spin systems coupled to NOE cross-peaks in NOESYexperiments and
are annotated above the 1-D spectrum with a single number corresponding to
those positions in the sequence of full-length Ad1213SE1A. (B) The amide-α
region of a two-dimensional NOESY experiment for Peptide 2 is presented
(conditions as for (A)). NOEs corresponding to cross-peaks within a single
residue are labelled with a single number corresponding to those positions in the
sequence of full-length Ad1213SE1A. NOEs that define medium range
connectivities of the type dN(i,i+2), dN(i,i+2), and two dN(i,i+3) are labelled
with both residue numbers. (C) Structure of Ad12E1A Peptide 2. The backbone
and side chain non-hydrogen atoms in the average calculated structure for Ad12
Peptide 2 from a conformational ensemble of 56 that converged in a total of
100 calculated is presented. Residues are labelled using the single-letter
abbreviation and position in the sequence of Ad1213SE1A. Initial structures for
the peptide were calculated in the absence of hydrogen bonds. However, five
hydrogen bonds were identified that corresponded to amide protons of low
temperature shift coefficients (Leu244, 1.9 ppb/K; Ile245, 2.5 ppb/K, Gln246,
2.0 ppb/K, Glu247, 2.5 ppb/K and Glu248, 2.0 ppb/K) which were included as
COiNHi+3 hydrogen bonds in the calculation of the structure shown. In the final
56 structures calculated, the average root mean square differences from the mean
structure were 0.87±0.12 Å for all atoms for the residues between Val254 and
Arg262 and 1.52±0.17 Å for all the non-hydrogen atoms. No distance restraint
was violated by more than 0.5 Å. α-helix is shown in red and β-turns in yellow.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Fig. 3. 1H NMR assignments for the 20-a.a. Ad12 Peptide 2 in the presence of CtBP1. One-dimensional 1H NMR spectra were recorded on a 100 μM sample of wild
type Peptide 1 in the absence (A) and presence (B) of 2 μM GST-CTBP (Peptide to protein ratio of 50:1) at 285 K in 25 mM [2H]Tris, adjusted to pH 7.4 with 2HCl.
Assignments for residues are based on individual spin systems identified in TOCSYexperiments coupled to through-space NOE cross-peaks determined from separate
two-dimensional NOESY experiments and are labelled using the sequence of Ad1213SE1A.
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is not certain from the data presented here whether a confor-
mational change also occurs within CtBP1 upon interaction with
the peptide (Fig. 4(C)).
Inspection of the crystal structure of CtBP3/BARS in the
presence of the PIDLSVKK peptide allows three significantobservations (Fig. 4(C); Nardini et al., 2003). Firstly, and most
strikingly, is the juxtaposition of the side chain aromatic ring of
F42 within the protein to I2 and L4 within the peptide and, as a
consequence, the formation of hydrogen bonds between the
protein and the peptide in the pattern F42–NH–CO–I2; F42–
CO–NH–L4 and within the peptide I2–CO–NH–L4. Except for
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proximity to K6 within the peptide (Fig. 4(C)), there are no other
aromatic amino acids within the region 22L–62A of CtBP3/
BARS (equivalent to residues 32L–A73 of CtBP1) and this most
likely provides an assignment for the aromatic 2,6 and 3,5 ring
protons of F53 in spectra for the Ad12 peptide in the presence of
CtBP1. Secondly, we observed the appearance of a new singlet
resonance upfield in the 1-D spectrum of the peptide in the
presence of GST-CtBP1. We noted from the crystal structure of
CtBP3/BARS the presence of V40 and A41, which are
sequentially adjacent to F42 (the corresponding residues in
CtBP1 are V51 and A52) and provide minimally two plausible
candidates for assignment of the observed upfield signal(s).
Thirdly, we observed a minor (<0.1 ppm) shift upfield in the
backbone amide resonances of V260 and K261 in the peptide.
Further inspection of the crystal structure for CtBP3/BARS
bound to the 8 a.a. peptide reveals that re-orientation of the
imidizole ring of H52 (equivalent to H63 in CtBP1) occurs upon
interaction with the peptide (Fig. 4(D)). Superimposition of the
Cα coordinates for two forms of CtBP3/BARS indicates only
minor (ca <0.05 Å) variations between the structures and the
significant changes in H52 must surely be peptide-induced. This
therefore has further implications for chemical modification of
K261 through acetylation and ultimately the regulatory effect of
this for possible E1A·CtBP-mediated transcription regulation.
Deletion analysis of the CtBP1-binding site of AdE1A
In further experiments designed to analyse the interaction
between the C-terminal region of Ad12E1A and CtBP in greater
detail the effects of single amino acid deletions across the
binding site on E1A were investigated using ELISAs to
determine the contribution of individual residues to the
interaction with CtBP1. These experiments were performed as
it was expected that deletion of individual residues would either
have repercussions for the secondary structural elements
required for recognition by CtBP1 or would disrupt the
conformation within the peptide associated with CtBP1
binding.
We observed that deletion of residues T253 (Peptide 3; Fig. 1)
and S259 (Peptide 9; Fig. 1) had little or no effect upon the
relative Kd (Fig. 1). In contrast removal of either V
254, V256,
L258 or V260 (Peptides 4, 6, 8 and 10, respectively; Fig. 1)
disrupts binding by approximately 3.2-, 2.5-, 2.7- and 4.4-fold,
respectively (Fig. 1). Deletion of these residues presumably
alters hydrophobic interactions with CtBP1, in agreement with
previous studies (Schaeper et al., 1995; Molloy et al., 1998). Of
further interest was the observation that deletion of V254, which
resides N-terminal to the PXDLS motif, has a slightly more
marked effect upon interactions with CtBP1 (ca∼1.2-fold) than
either V256 or L258 (Fig. 1). This merely confirms that binding
interactions are not solely restricted to the PVDLS motif and
this presumably disrupts the β-turn formed by residues N-
terminal to the binding domain. This is further confirmed by
results for the peptide carrying the deletion of V260, which
interacts with CtBP1 approximately 4.4-fold more weakly than
the wild type peptide (Peptide 1; Fig. 1). In spite of Kd values inthe low micromolar range the pool of CtBP1/Ad12E1A in Ad12
transformed or infected cells appears to be small (our
unpublished data). However, the substitutions/deletions in
peptides 3–12 increased the Kd by a few fold and would
probably decrease that rather small pool further if incorporated
into full-length proteins. Data for a peptide with a L→E
substitution at a.a. 258 is included for comparison. This
particular ‘mutation’ has a much more deleterious effect on
binding. No binding at all could be detected using a thrombin
receptor peptide.
From the NMR data it is now apparent that the Ad12 twenty
residue wild type peptide (Peptide 1; Fig. 1) adopts a helical
conformation in the presence of CtBP1 (Fig. 4(B)). As a direct
consequence V256, L258 and V260 become orientated in the same
direction and form a hydrophobic cluster that seems likely to
play a major role at the interface between the proteins in the
E1A·CtBP1 complex. In contrast, D257 and S259 which lie on
the opposite side of the helix are orientated away from the
hydrophobic cluster (Fig. 4(B)) and deletion of aspartic acid at
position 257 in Peptide 7 (Fig. 1) results in a radical reduction in
binding affinity for CtBP1 of approximately 5.4-fold (cf Peptide
1; Fig. 1). This finding demonstrates the essential role of
aspartate within the PXDLS motif as it most likely contributes
to a salt bridge formed between E1A and the target protein. It is
also evident from the calculated structure of the wild type
peptide bound to CtBP1 (Fig. 4(B)) that D257 within E1A is also
required as a geometric spacer and forms the first residue in the
second helical turn over the region P255–R262 in the bound state.
Rather less impact on the binding interactions between E1A
and CtBP1 is caused by the deletion of S259 (Peptide 9; Fig. 1).
The peptide carrying this deletion binds with a relative affinity of
3.4 μM (Fig. 1), which indicates that this residue contributes
significantly less to the interactions with CtBP1 than, for
example, D257. From the data presented in Fig. 1, it is clear that
deletion of P255 (Peptide 5; Fig. 1) dramatically alters the
binding affinity (ca∼4-fold). This occurs probably because this
residue acts as a ‘helix-inducer’ and controls not only re-
orientation of the PVDLS motif in the presence of CtBP1, but
also that for V256, which is essential for efficient interactions
with the target protein.
The influence of substitutions of negatively charged amino
acids on the interaction of Ad12 peptides with CtBP1
Having assessed the impact of deletion of Ad12E1A V256
on CtBP1 binding, the effect of ionic charge on the
interaction was investigated. We have already demonstrated
that synthetic peptides equivalent to the CtBP1-binding sites
within the Drosophila repressor, Snail, namely PEDLS and
PQDLS, adopt regular secondary structures in solution
(Molloy et al., 2001), suggesting that the requirement for a
hydrophobic residue at position 2 in the PXDLS motif is far
from absolute.
The ability of Ad12 synthetic peptides, specifically wild type
(Peptide 1; Fig. 1) and mutant peptides (Peptides 11 and 12,
which carry V256→E and V256→Q substitutions, respec-
tively), to bind to CtBP1 was assessed using fluorescence
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Fig. 5. Interactions between GST-CtBP1 and Ad12E1A peptides. Fluorescence spectroscopic titrations of 0.5 μM GST-CtBP in the presence of wild type Ad12E1A
Peptide 1 (A) and Peptides 11 (B) and 12 (C) which carry the V256E and P256Q substitutions, respectively within the CtBP binding site of E1A. Synthetic peptides
were added to give final concentrations of between 0 and 10 μMwith excitation at 265 nm. Fluorescence spectra were recorded between 300 and 400 nm at 23 °C. (D)
Binding affinities of E1A peptides for GST-CtBP. The average data from three experiments (±S.E.) are plotted against concentration of wild type (▪), V256E (▴) and
V256Q (▾) forms of the Ad12E1A peptide. The lines through each data set represent best fit of the data by the standard binding equation (see Materials and methods)
using values for Kd of 2.5×10
6, 5.6×106 and 6.4×106 M for wild type (—), V256E (- - -) and V256Q (– - - - – ) forms of the Ad12E1A peptide, respectively.
349D.P. Molloy et al. / Virology 363 (2007) 342–356spectroscopy. This is a rather more sensitive technique to study
protein–protein interactions than the ELISA. It also provides
details of subtle changes in the environment of the protein when
complexed to the target peptide. Spectra observed are due to
emissions from tyrosine and phenylalanine residues since
emission attributable to tryptophon is only evident after CtBP1
has been denatured in urea (our unpublished results). In each
case, binding interactions between CtBP1 and its partner peptide
were evidenced by a shift to a lower wavelength in the position
of the Emλmax of approximately 3 nm accompanied by an
appreciable decrease (of 12%, 17% and 19% for Peptides 11, 12
and 1, respectively) in fluorescence intensity of GST-CtBP1
(Fig. 5). In contrast, little or no difference was observed to occur
in fluorescence spectra of GST in the presence of any peptide nor
were any changes observed in the spectra of GST-CtBP1
following the addition of a peptide equivalent to the thrombinFig. 4. Structural properties of Ad12 Peptide 1 (247E–N266) in the presence of CtBP1
(mixing time, 200 ms duration) collected on a sample of Peptide 1 (at a concentratio
2H2O, pH 5.5, at 285 K is presented in the presence of 2 μM GST-CtBP. Residue ass
NOEs corresponding to cross-peaks within a single residue are labelled with a s
Ad1213SE1A. NOEs that define medium range connectivities of the type dN(i,i+2),
numbered 1, 2 and 3 pertain to new signals in the presence of the protein and represent
the backbone and side chain non-hydrogen atoms (ii) of eight superimposed structu
converged in a total of 100 calculated are presented. Residues are labelled using the
hydrogen bonds were identified that corresponded to amide protons of low tempera
which were included as COiNHi+3 hydrogen bonds in the calculation of the struct
differences from the mean structure were 0.727±0.12 Å for all atoms for the residues
distance restraint was violated by more than 0.5 Å. (C) A section of the crystal struct
(PDB accession number 1HL3) in the vicinity of the peptide-binding site is illustrat
(– - - –) formed between the peptide and protein (white backbone) are indicated. A
sequence of the peptide and full-length CTBP3/BARS protein. (D) Conformational
number 1HKU) and presence (yellow backbone) of the PIDLSVKK peptide (gree
position in the sequence of CtBP3BARS and using the single letter abbreviation and
references to colour in this figure legend, the reader is referred to the web versionreceptor peptide (Fig. 1) which is known not to interact with
CtBP1 (data not shown). The observed changes in fluorescence
intensity of GST-CtBP1, therefore, represent changes in the local
environment of the peptide-binding site on CtBP1 probably due
to changes in secondary structure allowing increased solvent
accessibility. In addition, a minor variation of approximately 5%
was observed at the end point titrations between Peptide 11 and
12 (cf wild type, Peptide 1; Fig. 5). This finding presumably
represents a slight difference in orientation of the peptides when
bound to CtBP1 as a direct consequence of the variation in
charge at position 256 of E1A. These data were also plotted as
the relative change in fluorescence intensity against peptide
concentration (Fig. 5(D)) and allowed values for Kds of 2.0, 5.6
and 6.4 μMfor the Peptides 1, 11 and 12, respectively, binding to
CtBP1 to be calculated. The introduction of a negative charge at
position 256 results in approximately a 2.8-fold decrease in. (A) The downfield amide-α region of a two-dimensional NOESY experiment
n of 100 μM) of sequence 247EEEREQTVPVDLSVKRPRCN266 in 10% (v/v)
ignments were identified from individual spin systems in TOCSY experiments.
ingle number corresponding to those positions in the sequence of full-length
dN(i,i+2), and two dN(i,i+3) are labelled with both residue numbers. The peaks
transferred NOEs between the protein and the peptide. (B) The C-α traces (i) and
res calculated for Ad12 Peptide 1 from a conformational ensemble of 47 that
single-letter abbreviation and position in the sequence of Ad1213SE1A. Three
ture shift coefficients (Ser259, 1.9 ppb/K; Val260, 2.5 ppb/K; Lys261, 2.0 ppb/K)
ure shown. In the final 47 structures calculated, the average root mean square
between Val254 and Arg262 and 1.46±0.17 Å for all the non-hydrogen atoms. No
ure of CtBP3/BARS complexed to a synthetic peptide of sequence PIDLSVKK
ed. The backbone of peptide is presented (red) and hydrogen bonding patterns
mino acids are labelled using the single letter abbreviation and position in the
changes in the backbone of CtBP3/BARS in the absence (blue PDB accession
n backbone). Amino acids are labelled using the three letter abbreviation and
position in the sequence of the PIDLSVKK peptide. (For interpretation of the
of this article.)
350 D.P. Molloy et al. / Virology 363 (2007) 342–356binding affinity (Peptide 11; Fig. 1). Slightly more detrimental to
CtBP1 binding interactions is the V256→Q substitution of E1A
(Peptide 12; Fig. 1) when relative binding affinity is reduced ca
∼3.2-fold.
As Peptides 11 and 12 have different affinities for CtBP1
their structures were examined further by NMR spectroscopy. 1-
D 1H NMR spectra were recorded for each in the absence and
presence of GST-CtBP1 in 10% (v/v) 2H2O, pH 5.5 (Fig. 6).
Corresponding spectra recorded for these peptides in the
absence and presence of GST revealed no significant differ-
ences in the peptide spectra (data not shown).
The interactions between Peptide 1 and GST-CtBP1 were
included in these experiments as a positive control and spectra
for the peptide in the absence and presence of GST-CtBP1 are
illustrated in Figs. 6(A and B (i) and (ii), respectively). At a ratio
of peptide to protein of 20:1, new proton signals deriving from
CtBP1 (see, for example, signals labelled O and * in Figs. 6(A
and B(ii))) were observed and these are equivalent to those
shown in Fig. 3(B).
Accounting for obvious differences between 1-D spectra
recorded in the absence of GST-CtBP1, for example, minor
shifts of amide protons of amino acids flanking each mutation,
up- (Peptide 11) or downfield (Peptide 12), the spectra are, onFig. 6. 1H NMR assignments for 20-a.a. Ad12 Peptides in the presence of CtBP1.
spectra for 100 μM samples of the wild type (Peptide 1) in the absence (i) and pres
absence (v) and presence (vi) of 5 μMGST-CtBP. Spectra were recorded in 10% 2H2
5 ms. Residue assignments were identified from individual spin systems coupled to N
number in the sequence of full-length Ad12 266-a.a. E1A.the whole, comparable to that for the wild type peptide. A
comparison of Peptides 11 and 12 (Figs. 6(A and B) (iii) and (v),
respectively) and Peptide 1 (Figs. 6(A and B (i))) confirms this.
In the presence of CtBP1 significant changes were observed in
the 1-D spectra for both Peptides 10 and 11 (see, for example,
E256 (Figs. 6(A and B (iv))) and Q256 (Figs. 6(A and B (vi)) cf
wild type; Figs. 6(A and B (ii)). These included line-broadening
of several peptide amide-NH proton signals and the appearance
of new protein proton signals in the downfield region of the 1-D
spectra (Fig. 6(A); labelled O). Once again, it was interesting to
observe the appearance of a new proton signal indicative of a
ring-shifted δ-CH3 signal in the upfield region of the spectra for
both peptides (labelled *; Fig. 6(B) (v) and Fig. 6(B) (vi),
respectively). It is noteworthy that this signal displayed
significant line-splitting in the spectrum for Peptide 12 (Fig. 6
(B) (vi)), whilst it appears as a singlet in spectra for Peptides 1
(Fig. 6(B) (ii)) and 11 (Fig. 6(B) (iv)). This observation leads to
the conclusion that, minimally, two hydrophobic residues
within CtBP1 contribute to binding interactions with the Ad12
peptides. It also confirms that the docking pattern for the Q256
peptide (Peptide 11) is significantly different to that displayed
by either E256 (Peptide 10) or wild type forms of the peptide as
a consequence of the V256→Q substitution.The downfield amide (A) and upfield aliphatic (B) regions of one-dimensional
ence (ii), Peptide 11 in the absence (iii) and presence (iv) and Peptide 12 in the
O, pH 5.5, at 285 K using a gated pre-saturation pulse of 1.1 s and a 90° pulse of
OE cross-peaks in NOESYexperiments using the single letter abbreviation and
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Ad12E1A peptides
As a consequence of replacing V256 in the Ad12E1A peptide
(Peptide 1; Fig. 1) with either glutamic acid or glutamine
(Peptides 10 and 11, respectively; Fig. 1), the relative
interactions of peptides equivalent to the C-terminus of this
protein with CtBP1 are reduced (ca∼3-fold; Fig. 1). Owing to a
plausible variation in the docking pattern of Peptide 11 to
CtBP1 (cf Peptides 1 and 10), as evidenced through
fluorescence and NMR spectroscopic investigations (see
above), it was of interest to assess the structural implications
of substitution at position 256 in E1A for the PXDLS motif.
Two-dimensional NMR spectra were recorded for Peptides
10 and 11 allowing the 3-D structures of each to be calculated
using XPLOR (Fig. 7). As we have described the structure of
Peptide 1 in detail elsewhere (Molloy et al., 1998, 2006), we
focus here upon comparison of Peptides 10 and 11 with Peptide
1, which forms a series of β-turns in solution (Molloy et al.,
1998). Peptide 10, which contains the PEDLS motif, displays a
2-D NMR spectral dispersion in the amide-α region similar to
that for Peptide 1 (data not shown). Over residues E247–R250
and R264–N266 at the N- and C-termini of Peptide 10,
respectively, the backbone forms frayed ends owing to theFig. 7. Structural properties of the V256–E and V256–Q forms of the Ad12 peptid
structures are shown out of the 32 that converged from 75 calculated. The α-car
Ad1213SE1A are labelled using the single-letter abbreviation and position in the
differences from the mean structure were 0.75±0.21 Å for all atoms of residues betw
restraint was violated by more than 0.5 Å. (B) The calculated structure for the V256–Q
from 60 calculated. Nomenclature as for (A). In the final 41 structures calculated, the
for all atoms of residues between Q256 and Arg262 and 1.55±0.17 Å for all non-hydabsence of long-range NOEs in these regions (Fig. 7(A)). Over
the remainder of the peptide, P255–V260, a number of NOEs of
the type dαN(i,i+2) P
255–D257, V256–L258, D257–S259 and
L258–V260, which were of equivalent intensity to dαN(i,i+3)
E256–S259 and D257–V260 (data not shown), define a series of
β-turns over this region as evidenced by a high correlation over
the backbone between the converged structures within the
conformation ensemble (Fig. 7(A)). Peptide 10, therefore,
adopts a structure remarkably similar to the wild type peptide
described earlier (Molloy et al., 1998, 2006). The observed 2.8-
fold reduction in binding affinity of this peptide (cf wild type;
(Fig. 1)) for CtBP1 can be explained solely by the introduction
of a negative charge at position 256 of E1A. This disrupts
formation of a hydrophobic interaction between the peptide and
CtBP1 in the E256-peptide·CtBP1 complex.
In a similar fashion, Peptide 11 (V256→Q; Fig. 1) was
examined by NMR spectroscopy and, once again, a pattern of
proton signals in the amide-α region of a 2-D 1H-NOESY
spectrum recorded in 10% 2H2O was not dissimilar to
corresponding spectra obtained for Peptide 1 and its calculated
structure is presented (Fig. 7(B)). Interestingly, it was noted that
some medium-range NOEs, for example, dαN(i,i+2) E
256–
L258, D257–S259 and dαN(i,i+3) E
256–S259, were absent from
spectra recorded for Peptide 11 and consequently it adopts a lesse. (A) The calculated structure for the V256–E peptide. Twelve superimposed
bon atoms are shown. Residues from the corresponding region of full-length
sequence. In the final 32 structures calculated, the average root mean square
een E256 and Arg262 and 1.42±0.15 Å for all non-hydrogen atoms. No distance
peptide. Nine superimposed structures are shown out of the 41 that converged
average root mean square differences from the mean structure were 0.79±0.26 Å
rogen atoms. No distance restraint was violated by more than 0.5 Å.
Fig. 8. Crystal structure of CtBP3/BARS in the presence of a PIDLSVKK
synthetic peptide and Ad12E1A synthetic peptides. (A) The crystal structure of
the binding protein and catalytic domains of CtBP3/BARS in the presence of a
synthetic peptide of sequence PIDLSVKK and NAD (PDB accession number
1HL3) is represented as a protein cartoon and the peptide is illustrated as Van der
Waal's spheres (red). The region that forms the site of interaction for the peptide
on CtBP is illustrated as non-hydrogen backbone and side chain atoms (orange).
Mutations within the catalytic domain known to influence CtBP interactions
with E1A are illustrated (white Van der Waal's spheres and white stick models).
(B) Three-dimensional model of wild type Ad12E1A peptide interactions with
CtBP3/BARS. The structure for the Ad12 peptide is labelled using the single
letter abbreviation and position in the sequence of E1A. CtBPBARS is indicated
by number in the sequence of the protein homologue from Ratus norvegicus.
Modelling studies were performed using the FTDOCK algorithm. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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Q256 and L258 (Fig. 7(B)). These findings provide an adequate
explanation for disruption of binding interactions between
Peptide 11 and CtBP1 (cf Peptide 1; (Fig. 1)). As a direct
consequence of this, replacement of V256 by Q not only disrupts
a hydrophobic bond formed between the peptide and CtBP1,
but also significantly alters the backbone conformation within
the PXDLS motif.
Taken together these findings confirm the minimal structural
elements required for Ad12E1A peptide binding to CtBP1
resides within the PXDLS motif. For stronger interactions,
notably involving an α-helix formed by residues N-terminal to
the motif, it is paramount that residues 255P–V260 serve two
purposes for the target protein, initially as a recognition site, and
secondly, as an anchor through a β→α conformational switch.
Discussion
Adenovirus E1A appears to function both in transformation
and infection through a series of protein–protein interactions
with host cell components. Based upon mutational analysis our
present knowledge of the binding sites on AdE1A for particular
target proteins is considerable. Rather limited use has also been
made of biochemical or structural studies using synthetic
peptides equivalent to specific regions of AdE1A in the study
of the relationship of structure to function. Using this latter
approach, however, we have previously demonstrated using
NMR spectroscopy that a 20 a.a. peptide identical to amino acids
247E–N266 (containing the 255PVDLS259 CtBP1-binding motif)
of Ad12E1A, adopts a series of β-turns in solution and interacts
with CtBP1 (Molloy et al., 1998). Furthermore, we have recently
shown that acetylation of K261 in a similar peptide disrupts at
least one β-turn (towards the C-terminus of the peptide) and this
most likely plays a noticeable but rather minor role in the
regulation of CtBP1·E1A binding (Molloy et al., 2006). In the
present study we have enlarged on our previous work and
investigated the structure of a larger AdE1A synthetic peptide
and, significantly, determined the structural changes occurring
on CtBP1 binding.
To date, two X-ray crystal structures are available for CtBP
(Kumar et al., 2002; Nardini et al., 2003). Of particular interest is
that in which the CtBP3/BARS protein is in a complex with an 8
a.a. PIDLSVKK peptide (Fig. 8(A)). This not only provides the
approximate location for the PXDLS binding site on the surface
of CtBP3/BARS, but also suggests that the PIDLSVKK peptide
adopts an extended conformation upon binding to the protein
(Fig. 8(B)). Our data presented here significantly expand upon
that study and provide substantially more information relevant to
E1A bound to CtBP1. Compared to the PIDLSVKK peptide
used in crystallographic studies (Nardini et al., 2003), the longer
Ad12 peptide(s) described here and previously have greater
propensity to adopt regular secondary structure. These structures
are defined by an N-terminal α-helix (this present study) and a
C-terminal series of β-turns across the PXDLS motif (Molloy
et al., 1998, 2006, Figs. 3 and 4). In addition, α-helices appear to
play a major role in protein–protein interactions and the β→α
conformational switch observed within the Ad12 peptide in thepresence of CtBP1 is more indicative of this feature of multi-
protein complex formation than can be inferred from the crystal
structure of the 8 a.a. peptide bound to CtBP3/BARS (Fig. 8(B)).
As a consequence of this, the PIDLSVKK peptide provides the
minimal and approximate location of the PXDLS motif-binding
site on CtBP3/BARS.
On the basis of our NMR spectroscopic study, a number of
conclusions can be drawn. Firstly, we noted that residues in the
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conformation in the absence of CtBP1 (Fig. 2(C)). In the
peptide model we have examined that the α-helix encompasses
amino acids L244 to Q252 It is quite possible, however, that this
α-helical region extends further towards the N-terminus in the
intact protein but this will have to await future analysis.
Secondly, we have observed a conformational change in the
amino acid sequence encompassing the PXDLS motif on CtBP1
binding. Thus within the amino acid sequence N-terminal to,
and encompassing, the PXDLS motif, structural propensity is
defined by an α-helix formed between residues 241I–V260 of
Ad12E1A and it seems likely that these additional structural
elements within the protein are likely to be of importance to the
interactions with CtBP1. To test the generality of this
suggestion, we performed structure predictions on regions of
CtBP binding proteins N-terminal to the PXDLS motif. We
observed that all E1As examined and several cellular CtBP
binding proteins (CtIP, Hairless, Hairy, Knirps and Snail) are
predicted to adopt an α-helical conformation N-terminal to the
motif. This finding suggests that many CtBP-binding proteins
are likely to interact with CtBP through a common mechanism
comparable to that determined for AdE1A. We propose the
following model:
E1Aþ CtBP1fE1A*•CtBP1fE1A•CtBP1
where, E1A and CtBP1 represent the full-length forms of the
proteins and preceding the formation of the biologically
significant E1A·CtBP1 complex, E1A undergoes a β→α
conformational switch to E1A* involving, minimally, the
PXDLS motif.
To what extent this type of binding reaction is representative
of other proteins interacting with AdE1A is not clear. However,
it is possible that the rather loosely structured E1A molecule
could become much more highly structured, following interac-
tions with other binding partners. Furthermore, it is possible that
interaction with one binding protein could result in structural
perturbations increasing (or decreasing) the affinity of E1A for
further interacting proteins. Again, these suggestions will have
to await detailed analysis to provide verification.
In the second part of this study, the effects of particular
“mutations” and deletions on the structures of Ad12 PVDLS-
containing peptides were examined. Consistent with previous
studies it has been shown that deletion of residues in the PXDLS
motif has considerable structural consequences. For example,
deletion of D257 not only disrupts geometrical constraints imposed
upon β→α isomerisation of the peptide backbone, but also, the
obvious deletion of the side chain γ-carboxylate oxygen, could
disrupt the propensity to form a salt bridge between E1A and a
positively charged residue within CtBP1. It should be noted,
however, that within the crystal structure of the PIDLSVKK
peptide, D3 projects out into the surrounding solvent and as such, is
unlikely to participate in ionic interactions with CtBP3/BARS. A
similar observation can be drawn fromourmodel for Peptide 1 (Fig.
1) bound to CtBP3/BARS (Fig. 8(C)).
Deletion of the adjacent residue to D257 and V256, had rather
less impact on the ability of the Ad12 peptide to interact with
CtBP1. The NMR data presented indicated that V256 detects anaromatic residue within CtBP1, as evidenced by the presence of
transferred NOEs in NOESY spectra for Peptide 1 in the
presence of CtBP1 (Fig. 4(A)). It is possible that V256 serves a
dual purpose in binding to CtBP1. Firstly, it contributes to the
β→α conformational switch driven by the preceding proline,
P255, and secondly it participates in hydrophobic interactions
with A49 within CtBP1 (A38 within CtBP3/BARS). Interest-
ingly, comparable spectral changes were observed in NOESY
experiments performed on a 77 a.a. fragment from the
C-terminus of Ad12E1A in the presence of CtBP1 (our un-
published data), suggesting that the Ad12 peptide(s) also closely
mimic the interactions between larger E1A fragments and
CtBP1. These findings are further supported by the observation
that substitution of V256→Q in synthetic peptides results in
severe structural implications for the PVDLS motif. Not only
does this influence the pattern and type of NOEs observed in 2-D
NOESY spectra but also significantly disrupts the PVDLS struc-
ture (Fig. 7(B)) and subsequent docking pattern with CtBP1.
Inspection of the primary sequence and 3D structure of
CtBP1 reveals the presence of 7 tyrosine, 9 phenylalanine and 4
tryptophan residues in this protein of which one, F42, in CtBP3/
BARS (F53 in CtBP1), is in close proximity to the PXDLS
binding site (ca ∼2 Å; Fig. 4(D)). It is notable that an emission
spectrum characteristic of tryptophan fluorescence can only be
obtained for CtBP1 in the presence of 8.0 M urea (our
unpublished data). The crystal structure for CtBP3/BARS
(Nardini et al., 2003) reveals that W residues are either localised
within the hydrophobic core of the protein or reside in the
catalytic domain >10Å away from the PXDLS binding site. As a
consequence these can be ruled out as candidates for assign-
ments of the aromatic residue involved in the isomerisation of
the Ad12E1A peptide backbone. Thus, inspection of the crystal
structure (Fig. 4(D)) reveals that one possible designation for
this residue is F42 (F53 within CtBP1), which lies adjacent to I2
(equivalent to V256 within the AdE1A peptide) in the crystal
structure of the 8 a.a. peptide bound to CtBP3/BARS (Nardini et
al., 2003). Therefore it appears that two-dimensional structural
changes occur in CtBP1 accompanying the binding and
transformation of the PXDLS-containing peptide.
Materials and methods
Protein preparation
Ad12E1A was expressed in E. coli strain DH-5α from the
pKK388-1 vector, purified and re-natured as described pre-
viously (Grand et al., 1998). CtBP1 was expressed in E. coli
strain TG2 from the pGEX-5X-3 vector as a fusion protein with
glutathione S-transferase as described (Grand et al., 1998).After
purification using glutathione agarose (Sigma) the GST-CtBP1
protein was dialysed against 0.15MNaCl, 50mMTris·HCl; pH
7.4, 1 mM DTT and stored at −80 °C until required.
Synthetic peptides
Twelve synthetic peptides used in this study were either
identical in sequence to portions of the extreme C-terminus of
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position T253 and V256, or were substituted at position 256
(Fig. 1). For convenience, all amino acids have been
numbered according to their position in the original
Ad1213SE1A protein, even when present in shorter synthetic
peptides. All peptides were synthesised using standard f-moc
procedures and purified by high performance liquid chroma-
tography on a Vydac C18 column eluted with a gradient of
acetonitrile (0–100%) containing 0.1% (v/v) trifluoroacetic
acid.
ELISA to quantify interactions between Ad12E1A peptides and
CtBP1
The interaction of peptides identical to the C-terminal
region of Ad12E1A or variants thereof (Fig. 1) with GST-
CtBP1 was examined using ELISA techniques as described
(Molloy et al., 1998, 2000, 2001). Briefly, ninety-six-well
plates were coated with purified Ad12E1A (0.1 μg/well) by
incubation overnight at 4 °C. E1A peptides, serially diluted
from 1.5 to 400 μg/ml, were mixed with GST-CtBP1 (12 μg/
ml) for 30 min at room temperature prior to addition to each
well. After addition of the peptide/GST-CtBP1 mixture and
incubation for 1 h at 37 °C, the plates were washed six times
with phosphate-buffered saline containing 0.1% Tween-80.
GST-CtBP1 bound to E1A on the plate was determined by
incubation with an antibody against GST (diluted 1:5000;
Amersham Pharmacia Biotech) followed by horseradish
peroxidase-linked antibody against goat IgG (1:1000 Santa
Cruz). After the addition of substrate, absorbance was de-
termined at 405 nm using a Bio-Tek plate reader. Determinations
were carried out in quadruplicate, and kinetic analysis was
performed (see below).
Fluorescence spectroscopy
Fluorescence spectra were measured using a Perkin-Elmer
LS50B luminescence spectrometer with an excitation wave-
length of 265 nm. Slit widths on both excitation and emission
monochromators were 2 nm. Buffer background was subtracted
from all spectra recorded. The absorption of samples was not
allowed to exceed 0.1 at the excitation wavelength to obviate
any requirement to correct data for inner-filter effects. Intrinsic
fluorescence measurements were made using a 1-cm path length
quartz fluorescence cuvette containing 5.0 mM Tris·HCl, pH
7.4 and 2 mM DTT at 23 °C. The emission intensity of GST-
CtBP1 fusion protein was measured between 285 and 400 nm.
Synthetic peptides were added to samples of 0.5 μM GST-
CtBP1 to give final concentrations of between 0 and 10 μM
from stock solutions, minimising dilution effects. Control
experiments were performed for GST under the same
conditions.
Kinetic analysis
The interactions between GST-CtBP1 and full-length
Ad12E1A and between GST-CtBP1 and synthetic peptidesidentical to portions of the C-terminus of Ad12E1A (Fig. 1)
were analysed using a non-linear least-squares approach. The
standard binding function,
Y ¼ Ymax•½L=½L þ Kd
was applied, where Y represents the percentage of E1A bound
to GST-CtBP1 in the presence of varying amounts of E1A
peptide, [L]. Kd represents the equilibrium binding constant,
and Ymax represents the end point for the binding interaction
(see, for example, Molloy et al., 1998). The affinity of CtBP1
for synthetic peptides was measured by competition with native
Ad12E1A, and Kd values are quoted as the mean values from
four experiments (±S.E.).NMR spectroscopy
All NMR spectra were recorded on a Bruker DMX 500 MHz
spectrometer essentially as described previously (Molloy et al.,
1998). Briefly, one-dimensional 1H NMR spectra were recorded
using a gated pre-saturation pulse of 1.5 s duration (to remove
the H2O signal) for accumulation over a 5050-Hz sweep width
with a 90° pulse of 5 μs. Spectra were recorded as free induction
decays (between 1024 and 2048 transients) and Fourier
transformed using a 2-Hz line broadening function. Two-
dimensional experiments were acquired with 2048 data points
in F2 with a sweep width of 11 ppm and with between 480 and
608 rows in F1. Solutions of peptides were 2 mM in
concentration routinely at 285 K and pH 5.5 in 50% (v/v) d3-
TFE/40% H2O/10%
2H2O or at pH 6.5 in 10% (v/v)
2H2O.
Deuterated dithiothreitol was added to all samples to give a final
concentration of 5 mM to prevent intermolecular disulphide
bridge formation. The water resonance was suppressed by very
weak pre-saturation applied through the WATERGATE
sequence and solvent artefacts were suppressed using pulsed
field gradients. Total correlation spectroscopy (TOCSY) used
an MLEV-17 mixing pulse of 60 ms duration (10 kHz spin
locking field). Nuclear Overhauser effect spectroscopy
(NOESY) experiments were performed using a mixing time
of 200 ms duration. Between 128 and 256 transients were
collected for TOCSY and NOESY experiments. One- and two-
dimensional spectra (ns=256) were recorded in the absence and
presence of GST-CtBP1, added by step-wise titration to final
ratios of peptide to protein of between 200:1 and 25:1 using a
solvent of 10% 2H2O pH 6.5.
Proton signals in TOCSY experiments were assigned to
identify spin systems within individual residues, which were
coupled to sequential (dαN i,i+1) NOE cross-peaks in NOESY
spectra. For proline residues, the δ-CH2 proton signals were used
in place of the dαN signals. The volume of each cross-peak was
integrated to estimate the distances between individual proton
signals within NOESYexperiments. The distances were grouped
into three classes, strong (1.8–2.5 Å), medium (1.8–4 Å) and
very weak (1.8–6.5 Å), with strong and mediumNOEs allocated
the same distance constraints in structural calculations. The
movement of chemical shifts of backbone amide protons with
changes in temperature between 285 and 305 K in TOCSY
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patterns within the peptides and was linear in every case. 3JHNα
coupling constants were calculated from two-dimensional
COSY experiments.
The structures of peptides were determined using X-PLOR
version 3.851 using initially the dg_sub_embed subroutine, in
which the CA, HA, N, HN, CB* and CG* atoms were
embedded. The remaining atoms were placed by template fitting
and the atomic coordinates were allowed to evolve under the
applied NOE distance constraints during the dgsa and refine
simulated annealing subroutines. From 100 structures gener-
ated, approximately 25–30 were discarded as these demon-
strated wrong-handedness in the distance geometry routine. The
remaining structures were chosen with no violations of the
applied NOEs of greater than 0.5 Å with a final 25 structures
accepted in the accept subroutine.
In summary, we have demonstrated here that amino acid
sequences encompassing the PVDLS motif in peptides
identical to the C-terminal region of Ad12E1A adopt a series
of β-turns. Sequences N-terminal to this are α-helical. On
binding to CtBP1 the α-helix extends towards the C-terminus
of Ad12E1A through the PVDLS motif. These observations
tend to support the proposition that AdE1A is structured, to
some extent, at least. On interaction AdE1A conformation is
modified, probably enhancing binding. Whether this occurs
for each AdE1A binding partner is not clear but seems likely.
Furthermore, it is quite possible that the conformational
changes could either enhance or diminish interaction with
other binding partners.
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